+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
ID07741721

Optimal Timing for Staged Complete Revascularization in STEMI Patients With Multivessel Disease Using Fractional Flow Reserve Guidance The OPTION-STEMI2 Trial

Led by Chonnam National University Hospital · Updated on 2026-10-23

1252

Participants Needed

30

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the best timing for staged complete revascularization using fractional flow reserve FFR in patients with ST-segment elevation myocardial infarction STEMI and multivessel coronary artery disease. This prospective, multicenter, open-label trial aims to compare in-hospital staged PCI of non-infarct related artery non-IRA lesions versus out-of-hospital staged PCI to determine which approach better reduces adverse cardiac events. The study addresses a gap in knowledge about optimal treatment timing following successful primary PCI of the infarct-related artery IRA.

CONDITIONS

Brief Title

Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)

Research Team

M

Min Chul Kim, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here